Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers

WHO convened an Advisory Group (AG) to consider the feasibility, potential value, and limitations of establishing a closely-monitored challenge model of experimental severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) in healthy adult volunt...

Full description

Saved in:
Bibliographic Details
Main Authors: Myron M. Levine, Salim Abdullah, Yaseen M. Arabi, Delese Mimi Darko, Anna P. Durbin, Vicente Estrada, Euzebiusz Jamrozik, Peter G. Kremsner, Rosanna Lagos, Punnee Pitisuttithum, Stanley A. Plotkin, Robert Sauerwein, Sheng Li Shi, Halvor Sommerfelt, Kanta Subbarao, John J. Treanor, Sudhanshu Vrati, Deborah King, Shobana Balasingam, Charlie Weller, Anastazia Older Aguilar, M. Cristina Cassetti, Philip R. Krause, Ana Maria Henao Restrepo
Other Authors: Faculty of Tropical Medicine, Mahidol University
Format: Review
Published: 2022
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/78189
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University
id th-mahidol.78189
record_format dspace
spelling th-mahidol.781892022-08-04T16:23:31Z Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers Myron M. Levine Salim Abdullah Yaseen M. Arabi Delese Mimi Darko Anna P. Durbin Vicente Estrada Euzebiusz Jamrozik Peter G. Kremsner Rosanna Lagos Punnee Pitisuttithum Stanley A. Plotkin Robert Sauerwein Sheng Li Shi Halvor Sommerfelt Kanta Subbarao John J. Treanor Sudhanshu Vrati Deborah King Shobana Balasingam Charlie Weller Anastazia Older Aguilar M. Cristina Cassetti Philip R. Krause Ana Maria Henao Restrepo Faculty of Tropical Medicine, Mahidol University Regional Centre for Biotechnology Centro para Vacunas en Desarrollo Chile King Saud bin Abdulaziz University for Health Sciences Ifakara Health Institute Universitetet i Bergen Wuhan Institute of Virology Chinese Academy of Sciences Universidad Complutense de Madrid Organisation Mondiale de la Santé University of Melbourne University of Rochester Medical Center Universitätsklinikum und Medizinische Fakultät Tübingen Bill and Melinda Gates Foundation Wellcome Trust Monash University National Institute of Allergy and Infectious Diseases (NIAID) Radboud Universiteit University of Maryland School of Medicine Food and Drug Administration University of Pennsylvania Johns Hopkins Bloomberg School of Public Health WHO RandD Blueprint COVID-19 Vaccines Working Group Centre de Recherches Médicales de Lambaréné Medicine WHO convened an Advisory Group (AG) to consider the feasibility, potential value, and limitations of establishing a closely-monitored challenge model of experimental severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) in healthy adult volunteers. The AG included experts in design, establishment, and performance of challenges. This report summarizes issues that render a COVID-19 model daunting to establish (the potential of SARS-CoV-2 to cause severe/fatal illness, its high transmissibility, and lack of a "rescue treatment"to prevent progression from mild/moderate to severe clinical illness) and it proffers prudent strategies for stepwise model development, challenge virus selection, guidelines for manufacturing challenge doses, and ways to contain SARS-CoV-2 and prevent transmission to household/community contacts. A COVID-19 model could demonstrate protection against virus shedding and/or illness induced by prior SARS-CoV-2 challenge or vaccination. A limitation of the model is that vaccine efficacy in experimentally challenged healthy young adults cannot per se be extrapolated to predict efficacy in elderly/high-risk adults. 2022-08-04T09:23:31Z 2022-08-04T09:23:31Z 2021-06-01 Review Clinical Infectious Diseases. Vol.72, No.11 (2021), 2035-2041 10.1093/cid/ciaa1290 15376591 10584838 2-s2.0-85094964919 https://repository.li.mahidol.ac.th/handle/123456789/78189 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85094964919&origin=inward
institution Mahidol University
building Mahidol University Library
continent Asia
country Thailand
Thailand
content_provider Mahidol University Library
collection Mahidol University Institutional Repository
topic Medicine
spellingShingle Medicine
Myron M. Levine
Salim Abdullah
Yaseen M. Arabi
Delese Mimi Darko
Anna P. Durbin
Vicente Estrada
Euzebiusz Jamrozik
Peter G. Kremsner
Rosanna Lagos
Punnee Pitisuttithum
Stanley A. Plotkin
Robert Sauerwein
Sheng Li Shi
Halvor Sommerfelt
Kanta Subbarao
John J. Treanor
Sudhanshu Vrati
Deborah King
Shobana Balasingam
Charlie Weller
Anastazia Older Aguilar
M. Cristina Cassetti
Philip R. Krause
Ana Maria Henao Restrepo
Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers
description WHO convened an Advisory Group (AG) to consider the feasibility, potential value, and limitations of establishing a closely-monitored challenge model of experimental severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19) in healthy adult volunteers. The AG included experts in design, establishment, and performance of challenges. This report summarizes issues that render a COVID-19 model daunting to establish (the potential of SARS-CoV-2 to cause severe/fatal illness, its high transmissibility, and lack of a "rescue treatment"to prevent progression from mild/moderate to severe clinical illness) and it proffers prudent strategies for stepwise model development, challenge virus selection, guidelines for manufacturing challenge doses, and ways to contain SARS-CoV-2 and prevent transmission to household/community contacts. A COVID-19 model could demonstrate protection against virus shedding and/or illness induced by prior SARS-CoV-2 challenge or vaccination. A limitation of the model is that vaccine efficacy in experimentally challenged healthy young adults cannot per se be extrapolated to predict efficacy in elderly/high-risk adults.
author2 Faculty of Tropical Medicine, Mahidol University
author_facet Faculty of Tropical Medicine, Mahidol University
Myron M. Levine
Salim Abdullah
Yaseen M. Arabi
Delese Mimi Darko
Anna P. Durbin
Vicente Estrada
Euzebiusz Jamrozik
Peter G. Kremsner
Rosanna Lagos
Punnee Pitisuttithum
Stanley A. Plotkin
Robert Sauerwein
Sheng Li Shi
Halvor Sommerfelt
Kanta Subbarao
John J. Treanor
Sudhanshu Vrati
Deborah King
Shobana Balasingam
Charlie Weller
Anastazia Older Aguilar
M. Cristina Cassetti
Philip R. Krause
Ana Maria Henao Restrepo
format Review
author Myron M. Levine
Salim Abdullah
Yaseen M. Arabi
Delese Mimi Darko
Anna P. Durbin
Vicente Estrada
Euzebiusz Jamrozik
Peter G. Kremsner
Rosanna Lagos
Punnee Pitisuttithum
Stanley A. Plotkin
Robert Sauerwein
Sheng Li Shi
Halvor Sommerfelt
Kanta Subbarao
John J. Treanor
Sudhanshu Vrati
Deborah King
Shobana Balasingam
Charlie Weller
Anastazia Older Aguilar
M. Cristina Cassetti
Philip R. Krause
Ana Maria Henao Restrepo
author_sort Myron M. Levine
title Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers
title_short Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers
title_full Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers
title_fullStr Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers
title_full_unstemmed Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers
title_sort viewpoint of a who advisory group tasked to consider establishing a closely-monitored challenge model of coronavirus disease 2019 (covid-19) in healthy volunteers
publishDate 2022
url https://repository.li.mahidol.ac.th/handle/123456789/78189
_version_ 1763489632052314112